Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1Gynecologic 1

Conditions

Diffuse Intrinsic Pontine Glioma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Obesity 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Glioma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Disease 1Carcinosarcoma 1

Interventions

Blood Specimen Collection 3Observation 2Magnetic Resonance Imaging 2Biopsy 2tislelizumab 1pembrolizumab 1fluorocholine 1atezolizumab 1abiraterone 1Videotape Recording 1TIC10 compound 1Surveys and Questionnaires 1Specimen Handling 1Referral and Consultation 1Prostatectomy 1Preoperative Exercise 1Prednisone 1Positron Emission Tomography Computed Tomography 1Pluvicto 1Nephroureterectomy 1Mass Screening 1Mammography 1Interleukin-15 1High-Intensity Interval Training 1Food 1Endosonography 1Educational Status 1Diagnostic Techniques and Procedures 1Diagnostic Imaging 1Defecation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Disease × TIC10 compound × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡